Compare OCGN & EBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | EBF |
|---|---|---|
| Founded | 2013 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.8M | 538.9M |
| IPO Year | 2014 | 1994 |
| Metric | OCGN | EBF |
|---|---|---|
| Price | $1.10 | $22.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.75 | N/A |
| AVG Volume (30 Days) | ★ 8.0M | 122.3K |
| Earning Date | 05-05-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 4.85% |
| EPS Growth | N/A | ★ 7.79 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.96 |
| Revenue Next Year | $1,718.38 | N/A |
| P/E Ratio | ★ N/A | $57.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.97 | $16.30 |
| 52 Week High | $2.73 | $22.94 |
| Indicator | OCGN | EBF |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 63.86 |
| Support Level | $0.97 | $20.81 |
| Resistance Level | $1.49 | $22.46 |
| Average True Range (ATR) | 0.06 | 0.42 |
| MACD | 0.00 | 0.13 |
| Stochastic Oscillator | 76.92 | 81.22 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Ennis Inc is a trade printer company that manufactures a broad range of printed products throughout the United States. It is engaged in the business of manufacturing, designing, and selling business forms and other printed business products to distributors located in the United States. Through a network of independent distributors, its channel encompasses independent print distributors, commercial printers, direct mail, fulfillment companies, payroll and accounts payable software companies, and advertising agencies, among others. The group operates in a single reportable segment called Print and derives its operating revenues from the manufacturing of mostly custom or semi-custom printed products sold mostly to independent distributors in the United States.